Medica Holdings, LLC
Contact us:
  • News
  • IP
  • Quality
  • About Us
  • Contact

Medica receives FDA 510(k) clearance for Medicant Mucosal Atomizer

4/6/2018

 
LAKE OSWEGO, OR, April 6, 2018  Medica Holdings, Inc. is pleased to announce that the Medicant Mucosal Atomizer (MMA), has received 510(k) clearance from the United States Food & Drug Administration (FDA). The MMA allows for the non-invasive delivery of medication directly to a patient’s blood stream via their mucosal membranes.  The device will be available in three styles; MMA Rhinal™ for nasal applications, 4.5” and 8.5” for delivery directly to the laryngo-tracheal region via a wand-like configuration. The MMA Rhinal™ is for use with drugs approved for intranasal delivery, all supplied with a 3 cc syringe.

Medica receives expanded FDA 510(k) clearance for VibraPEP® with combined aerosol treatment.

2/21/2017

 
​LAKE OSWEGO, OR, February 21, 2017 -- Medica Holdings, Inc. has received FDA clearance (K163091) for its VibraPEP® Oscillatory PEP (OPEP) System expanding the indications for use to include connecting a Valved Tee Adapter for use with a jet nebulizer for aerosol drug delivery.  This combination of aerosol treatments with OPEP saves time and enhances medication deposition.

Medica receives FDA 510(k) clearance for VibraPEP®

3/25/2016

 
​LAKE OSWEGO, OR, March 25, 2016 -- Medica Holdings, LLC has received FDA clearance (K153441) for its VibraPEP® Oscillatory PEP (OPEP) System.  The VibraPEP™ Mucus Clearing Device is a Positive Expiratory Pressure, PEP Device. It was designed to exercise patient's lungs and to improve secretion clearance.

    Archives

    June 2018
    April 2018
    January 2018
    August 2017
    April 2017
    February 2017
    January 2017
    October 2016
    March 2016

    Categories

    All
    FDA Clearance
    ISO Certification
    News
    Patents
    Trademarks

    RSS Feed

log-in            Pre-Ship
(c) Medica Holdings, LLC